Company Overview of CellControl Biomedical Laboratories AG
CellControl Biomedical Laboratories AG develops anti-idiotypic antibodies which trigger immune response against cancer tumour cells. The company was founded in 1995 and is based in Planegg, Germany.
Am Klopferspitz 19
Founded in 1995
49 49 89 89 52 75 0
49 89 89 52 75 11
Key Executives for CellControl Biomedical Laboratories AG
CellControl Biomedical Laboratories AG does not have any Key Executives recorded.
Similar Private Companies By Industry
|3B Pharmaceuticals GmbH||Europe|
|Accelsiors Group International||Europe|
|Aenova Group GmbH||Europe|
|Aenova Holding GmbH||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact CellControl Biomedical Laboratories AG, please visit www.cellcontrol.de. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.